Search Results 81-90 of 1341 for ✔[광고텔레:SEOGOT] 구글야동사이트홍보 장집홍보 대포유심삽니다 게임핵 선불유심팝니다 해외선물솔루션홍보 상위노출대행 신용카드현금화하는법 010실명인증구입 슬롯커뮤니티홍보✔

  1. A Study to Create a Registry of Non-Fusion Spinal Deformity Correction in Adolescent Idiopathic Scoliosis - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of non-fusion surgical treatment of Spinal Deformity Correction in Adolescent Idiopathic ...

  2. Clinical Trials - Behavior of Valve Leaflets

    This is a prospective, interventional, multi-center trial to report the overall incidence of reduced leaflet motion identified by CT imaging in patients ...

  3. A Study to Analyze Intracerebral Hemorrhage Hematoma - Mayo Clinic

    The purpose of this study is to to take the usual waste material from the removal of hematoma and apply an array of -Omics approaches (including for example ...

  4. Matthew A. Warner, M.D. - Mayo Clinic Faculty Profiles

    Warner, M.D., studies patient blood management. Focus areas include clinical and translational research in the space of anemia, coagulopathy, hemorrhage and ...

  5. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    The purpose of this research study is to determine the maximum tolerated dose and safety of three drug combinations. Each combination is assigned to a different ...

  6. Mine Cicek, Ph.D. - Mayo Clinic Faculty Profiles

    Molecular cancer genetic epidemiologist Mine Cicek, Ph.D., leads the Mayo Clinic Biorepositories Program.

  7. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

    Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

  8. A Study to Evaluate the Safety and Effectiveness of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of OMS721 in patients with IgA nephropathy. The study will assess proteinuria by 24-hour ...

  9. Elizabeth A. Boots, Ph.D., L.P. - Mayo Clinic Faculty Profiles

    Elizabeth A. Boots, Ph.D., L.P., studies the cognitive and brain changes that occur in aging, mild cognitive impairment, and dementia due to Alzheimer's disease ...

  10. A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy Duration - Mayo Clinic

    A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...